These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. New trends in Clostridium difficile virulence and pathogenesis. Denève C; Janoir C; Poilane I; Fantinato C; Collignon A Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S24-8. PubMed ID: 19303565 [TBL] [Abstract][Full Text] [Related]
25. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors. Sundram F; Guyot A; Carboo I; Green S; Lilaonitkul M; Scourfield A J Hosp Infect; 2009 Jun; 72(2):111-8. PubMed ID: 19386381 [TBL] [Abstract][Full Text] [Related]
26. Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. Borgmann S; Kist M; Jakobiak T; Reil M; Scholz E; von Eichel-Streiber C; Gruber H; Brazier JS; Schulte B Euro Surveill; 2008 Dec; 13(49):. PubMed ID: 19081002 [TBL] [Abstract][Full Text] [Related]
27. [Epidemiology of Clostridium difficile PCR ribotype 027 in the Netherlands 2005-present and the emergence of other subtypes]. Notermans DW; van der Kooi TI; Goorhuis A; Debast SB; van Benthem BH; Kuijper EJ Ned Tijdschr Geneeskd; 2008 Aug; 152(35):1937-40. PubMed ID: 18808085 [TBL] [Abstract][Full Text] [Related]
29. Clostridium difficile and fluoroquinolones: is there a link? Weiss K Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S29-32. PubMed ID: 19303566 [TBL] [Abstract][Full Text] [Related]
30. Treatment of clostridium difficile colitis in the critical care setting. Musher DM; Aslam S Crit Care Clin; 2008 Apr; 24(2):279-91, viii. PubMed ID: 18361946 [TBL] [Abstract][Full Text] [Related]
31. Isolation of Clostridium difficile ribotype 027, toxinotype III in the Netherlands after increase in C. difficile-associated diarrhoea. van Steenbergen J; Debast S; van Kregten E; van den Berg R; Notermans D; Kuijper E Euro Surveill; 2005 Jul; 10(7):E050714.1. PubMed ID: 16785657 [No Abstract] [Full Text] [Related]
33. Treatment of first recurrences of Clostridium difficile-associated disease: waiting for new treatment options. Louie TJ Clin Infect Dis; 2006 Mar; 42(6):765-7. PubMed ID: 16477550 [No Abstract] [Full Text] [Related]
34. Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Biller P; Shank B; Lind L; Brennan M; Tkatch L; Killgore G; Thompson A; McDonald LC Infect Control Hosp Epidemiol; 2007 Feb; 28(2):198-201. PubMed ID: 17265402 [TBL] [Abstract][Full Text] [Related]
36. Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea. Carman RJ; Genheimer CW; Rafii F; Park M; Hiltonsmith MF; Lyerly DM Anaerobe; 2009 Dec; 15(6):244-8. PubMed ID: 19818865 [TBL] [Abstract][Full Text] [Related]
37. Update on the changing epidemiology of Clostridium difficile-associated disease. McFarland LV Nat Clin Pract Gastroenterol Hepatol; 2008 Jan; 5(1):40-8. PubMed ID: 18174906 [TBL] [Abstract][Full Text] [Related]
38. CE offering--introductory offer Clostridium difficile associated disease (CDAD). Segal P Pa Nurse; 2007 Jun; 62(2):18-9, 21; quiz 21-2. PubMed ID: 17668836 [No Abstract] [Full Text] [Related]
39. Clostridium difficile-associated diarrhea outbreaks: the name of the game is isolation and cleaning. Beaulieu M; Thirion DJ; Williamson D; Pichette G Clin Infect Dis; 2006 Mar; 42(5):725; author reply 727-9. PubMed ID: 16447122 [No Abstract] [Full Text] [Related]
40. Preventing clostridium difficile infection in the intensive care unit. Zilberberg MD; Shorr AF Crit Care Clin; 2013 Jan; 29(1):11-8. PubMed ID: 23182524 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]